Why We Made a Mobile Digital Pathology Lab

• by Helen Bristow

• May 29, 2026

Could One Test Replace Multiple Leukemia Assays?

Researchers assess whether long-read transcriptome sequencing can streamline B-ALL diagnostics

• May 29, 2026

• 3 min

Preclinical Study in Mice Addresses a Question: Should RAS Inhibitors Be Given Preemptively?

With recent data that RAS inhibition can improve survival in metastatic pancreatic cancer, the optimization of these agents has become a research priority. Minh Than, MD, PhD, a clinical and research ...

• by Caroline Helwick

• May 28, 2026

• 4 min

FDA Approves Durvalumab Plus BCG for High-Risk NMIBC

On May 28, 2026, the U.S. Food and Drug Administration (FDA) approved the PD-L1 inhibitor durvalumab (Imfinzi) in combination with bacillus Calmette-Guérin (BCG) for the treatment of adult patients wi...

• by The ASCO Post Staff

• May 28, 2026

• 2 min